Charles River and Akron Bio have announced the integration of the latter’s CSS liquid cytokines into the former's Cell ...

For full year 2024, the Company expects total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS to be at or above the ...

AQST-108 (epinephrine) Topical Gel Aquestive successfully completed a pre-Investigational New Drug meeting with the FDA in December 2024. The written response received from the FDA was supportive of ...

Source: FactSet Data are provided 'as is' for informational purposes only and are not intended for trading purposes ... for a particular purpose or use; and (b) shall not be liable for any ...

Indonesia's Health Ministry is expediting efforts to achieve domestic pharmaceutical independence to address the evolving ...

For full year 2024, the Company expects total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS to be at or above the guidance ranges provided on November 8, 2024Rare Disease ...

A possibly more problematic feature could be the impact tariffs have on the U.S. industries that are reliant on imported raw materials ... The failure to include pharmaceutical pricing reforms ...

Four Japanese drugmakers – Astellas, Eisai, Daiichi Sankyo, and Takeda – have joined forces in a partnership intended to reduce the environmental impact of pharmaceutical packaging. The ...

The information contained in this announcement is not intended to be an offer for subscription ... Telix's ability to obtain an adequate supply of raw materials at reasonable costs for its products ...